Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma [Phase 1]
A Phase 1 trial is evaluating the safety and potential benefit of Vitamin B5 (pantothenic acid) in patients with melanoma. The study is curr…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma [Phase 1]
This is a Phase 1 clinical trial evaluating MEDI0562 before surgical resection in head and neck squamous cell carcinoma or melanoma; the stu…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Beta-only IL-2 ImmunoTherapY Study [Phase 1, Phase 2]
Medicennа Therapeutics is evaluating a beta-only IL-2 immunotherapy (MDNA11) in Phase 1/2 across multiple advanced solid tumors; recruitment…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma [Phase 3]
Clinical trial update on a Phase 3 neoadjuvant study of BCD-217 (Nurulimab + Prolgolimab) in patients with resectable Stage III skin melanom…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating nivolumab with hydroxychloroquine or nivolumab with ipilimumab plus hydroxychloroquine in advanced melan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin [Phase 3]
Phase 3 clinical trial evaluating BCD-263 and Opdivo as monotherapy for advanced melanoma of the skin; the study status is ACTIVE_NOT_RECRUI…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study [NA]
A clinical trial comparing anti-PD-1 therapy with and without a postbiotic in treatment-naïve locally advanced or metastatic cutaneous melan…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders [Phase 2]
A Phase 2 clinical trial at Oslo University Hospital is testing fecal microbiota transplantation from clinical responders in cancer patients…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
A recruiting clinical study from University Health Network evaluating a non-invasive AI-based platform for patient monitoring, named NIP IT!…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Using QPOP to Predict Treatment for Sarcomas and Melanomas
A recruiting clinical study from the National Cancer Centre, Singapore evaluating the QPOP method to predict effective treatments for patien…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Preoperative Planning With PSMA-PET in Melanoma Surgery Trial [Phase 2]
Phase 2 clinical trial evaluating PSMA-PET imaging to assist preoperative planning in melanoma surgery is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma [Phase 2]
This document describes a Phase II clinical trial evaluating a PD-L1 inhibitor in combination with anti-VEGF therapy for unresectable or met…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) [Phase 2]
Phase 2 clinical trial assessing prophylactic mesalamine to prevent colitis after treatment with ipilimumab and nivolumab in patients with a…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1 [Phase 1, Phase 2]
An update on a Phase 1/2 study evaluating the safety and efficacy of OPM-101 combined with anti-PD-1 in advanced melanoma that has shown res…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma [Phase 2]
A Phase 2 clinical trial is evaluating whether sulforaphane, a compound found in cruciferous vegetables, can help prevent melanoma in patien…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors [NA]
A clinical trial update investigating autologous tumor-infiltrating lymphocyte therapy for melanoma patients who failed immune checkpoint in…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy [Phase 2]
This Phase 2 study investigates adaptive dosing of the combination of ipilimumab and nivolumab for metastatic melanoma and is currently acti…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: APA (Adapted Physical Activity) for Patients With Advanced Melanoma
A clinical trial is recruiting to assess Adapted Physical Activity for patients with advanced melanoma.
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors [Phase 2]
A Phase 2 clinical trial by Iovance Biotherapeutics evaluating autologous tumor-infiltrating lymphocytes in solid tumors is currently recrui…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery
ClinicalTrials.gov entry for a study on glutamate excitotoxicity in brain metastases from lung cancer, breast cancer, and melanoma treated w…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors [Phase 1]
BA1302 from Shandong Boan Biotechnology Co., Ltd is in Phase 1 testing for advanced solid tumors, with non-small cell lung cancer, pancreati…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO [Phase 3]
A Phase 3 trial is evaluating whether an immune-oncology therapy given every three months after six months of standard administration is as …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study [Phase 4]
This ClinicalTrials.gov entry describes a Phase 4, single-arm exploratory study evaluating iparomlimab and tuvonralimab in combination with …
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies [Phase 1]
A Phase 1 clinical trial evaluating the safety and tolerability of AWT020 in patients with advanced malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
A clinical trial evaluating whether blocking tumor necrosis factor (TNF) can enhance immune checkpoint inhibitor–driven immune activation in…